Venous Vascular Closure System Versus Conventional Figure of Eight Suture Following Single Shot Device Pulmonary Vein Isolation: The VASC-AF Study

AIMS: Optimization of femoral venous access management has become increasingly important as catheter ablation of atrial fibrillation (AF) continues to evolve towards greater safety with accelerated recovery pathways. We evaluated the efficacy and safety of a bioabsorbable venous vascular closure system (VCS) compared with a conventional figure-of-eight (F8) suture and manual compression following contemporary single-shot pulmonary vein isolation (PVI). METHODS AND RESULTS: VASC-AF was a prospective, multicentre, randomized controlled trial performed at three German electrophysiology centres. One hundred consecutive patients undergoing single-shot PVI were randomized in a 1:1 ratio to femoral venous closure using the VASCADE MVP VCS; (n=50) or conventional F8 suture (n=50). The primary efficacy endpoint was time to ambulation. The primary safety endpoint comprised major periprocedural adverse events requiring medical intervention before hospital discharge.Baseline characteristics and procedural variables were comparable between study groups. Median time to ambulation was significantly shorter following vascular closure with VCS compared with F8 sutures (120 [120-150] vs. 180 [180-240] min; P=0.015). Likewise, time to haemostasis (0.5 [0.5-2] vs. 1 [1-2] min; P=0.021) and time to discharge eligibility (2.5 [2.1-3.0] vs. 4.0 [3.0-5.0] h; P=0.019) were significantly reduced.Major adverse events occurred infrequently and did not differ significantly between groups. In contrast, vascular closure using VCS significantly reduced minor vascular access complications (6% vs. 26%; P=0.006), groin pain, and patient discomfort while improving overall post-procedural satisfaction. CONCLUSION: Among patients undergoing contemporary single-shot AF ablation, use of a bioabsorbable VCS significantly accelerated post-procedural recovery while maintaining a comparable major safety profile. Reduced access-site complications and improved patient-reported outcomes support VCS as an important component of enhanced recovery pathways following AF ablation especially in an ambulatory or Same-Day Discharge setting.

Authors

Institutions

Publication Details

Journal
EP Europace
Published
2026-11-18
DOI
https://doi.org/10.1093/europace/euag329
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Venous Vascular Closure System Versus Conventional Figure of Eight Suture Following Single Shot Device Pulmonary Vein Isolation: The VASC-AF Study

Tilman Maurer, Henning Rolfes, Fariba Rafiee, Julia Vogler et al.
3 links
EP Europace
Atrial Fibrillation Management and Outcomes
article

Venous Vascular Closure System Versus Conventional Figure of Eight Suture Following Single Shot Device Pulmonary Vein Isolation: The VASC-AF Study

Tilman Maurer, Henning Rolfes, Fariba Rafiee, Julia Vogler, Christian-Hendrik H. Heeger, Martin Bergmann, Stephan Willems, Arian Sultan, Alexander Ghanem, Annalena Feibel, Louis Töllner
article en

Abstract

AIMS: Optimization of femoral venous access management has become increasingly important as catheter ablation of atrial fibrillation (AF) continues to evolve towards greater safety with accelerated recovery pathways. We evaluated the efficacy and safety of a bioabsorbable venous vascular closure system (VCS) compared with a conventional figure-of-eight (F8) suture and manual compression following contemporary single-shot pulmonary vein isolation (PVI). METHODS AND RESULTS: VASC-AF was a prospective, multicentre, randomized controlled trial performed at three German electrophysiology centres. One hundred consecutive patients undergoing single-shot PVI were randomized in a 1:1 ratio to femoral venous closure using the VASCADE MVP VCS; (n=50) or conventional F8 suture (n=50). The primary efficacy endpoint was time to ambulation. The primary safety endpoint comprised major periprocedural adverse events requiring medical intervention before hospital discharge.Baseline characteristics and procedural variables were comparable between study groups. Median time to ambulation was significantly shorter following vascular closure with VCS compared with F8 sutures (120 [120-150] vs. 180 [180-240] min; P=0.015). Likewise, time to haemostasis (0.5 [0.5-2] vs. 1 [1-2] min; P=0.021) and time to discharge eligibility (2.5 [2.1-3.0] vs. 4.0 [3.0-5.0] h; P=0.019) were significantly reduced.Major adverse events occurred infrequently and did not differ significantly between groups. In contrast, vascular closure using VCS significantly reduced minor vascular access complications (6% vs. 26%; P=0.006), groin pain, and patient discomfort while improving overall post-procedural satisfaction. CONCLUSION: Among patients undergoing contemporary single-shot AF ablation, use of a bioabsorbable VCS significantly accelerated post-procedural recovery while maintaining a comparable major safety profile. Reduced access-site complications and improved patient-reported outcomes support VCS as an important component of enhanced recovery pathways following AF ablation especially in an ambulatory or Same-Day Discharge setting.

EP Europace
University of Cologne (DE), Asklepios Klinik Altona (DE), Asklepios Klinik St. Georg (DE), Asklepios (DE), Asklepios Kliniken Hamburg (DE), University of Lübeck (DE)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon